Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability

Contrasting effects of cardiac glycosides on cisplatin- and etoposide-induced cell death

(2016) Andrey V. Kulikov et al.   BIOLOGICAL CHEMISTRY

Digoxin is a selective modifier increasing platinum drug anticancer activity

(2016) T. A. Bogush et al.   Doklady Biochemistry and Biophysics

Beneficial Renal and Pancreatic Phenotypes in a Mouse Deficient in FXYD2 Regulatory Subunit of Na,K-ATPase

(2016) Elena Arystarkhova   Frontiers in Physiology

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

(2014) Domenica Lorusso et al.   GYNECOLOGIC ONCOLOGY

21-Benzylidene Digoxin: A Proapoptotic Cardenolide of Cancer Cells That Up-Regulates Na,K-ATPase and Epithelial Tight Junctions

(2014) Sayonarah C. Rocha et al.   PLoS One

Ouabain-Induced Alterations of the Apical Junctional Complex Involve α1 and β1 Na,K-ATPase Downregulation and ERK1/2 Activation Independent of Caveolae in Colorectal Cancer Cells

(2013) Waldemir Fernandes de Souza et al.   JOURNAL OF MEMBRANE BIOLOGY

The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact

(2013) J M Calderón-Montaño et al.   ONCOGENE

Cisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells

(2013) Qi Niu et al.   Frontiers in Genetics

Covalent binding of cisplatin impairs the function of Na+/K+-ATPase by binding to its cytoplasmic part

(2012) Miroslav Huličiak et al.   BIOCHEMICAL PHARMACOLOGY

MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells

(2012) Jean-Philippe Guégan et al.   CARCINOGENESIS

Contribution of intracellular ATP to cisplatin resistance of tumor cells

(2012) Verena Schneider et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Comparative Properties of Caveolar and Noncaveolar Preparations of Kidney Na+/K+-ATPase

(2011) Lijun Liu et al.   BIOCHEMISTRY

Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model

(2011) Cheng Tien Wu et al.   FREE RADICAL BIOLOGY AND MEDICINE

Regulatory phosphorylation of FXYD2 by PKC and cross interactions between FXYD2, plasmalemmal Ca-ATPase and Na,K-ATPase

(2010) Vanessa Faria Cortes et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents

(2010) Atsushi Yonezawa et al.   BIOCHEMICAL PHARMACOLOGY

Alterations of Na+/K+-ATPase function in caveolin-1 knockout cardiac fibroblasts

(2010) Luis E.M. Quintas et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Changes in Sodium Pump Expression Dictate the Effects of Ouabain on Cell Growth

(2009) Jiang Tian et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets

(2009) A. Y. Bagrov et al.   PHARMACOLOGICAL REVIEWS

Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B

(2008) Zunaid Ahmed et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades

(2008) Zhichuan Li et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

(2007) Matthew D. Hall et al.   Annual Review of Pharmacology and Toxicology